+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Etafenone Market by Application, Distribution Channel, End User, Form - Global Forecast to 2030- Product Image
Etafenone Market by Application, Distribution Channel, End User, Form - Global Forecast to 2030- Product Image
Sale

Etafenone Market by Application, Distribution Channel, End User, Form - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015379
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Etafenone Market is gaining momentum as healthcare providers and suppliers seek efficient solutions to address evolving cardiovascular needs. Etafenone's multi-action therapeutic profile is positioning it as a flexible option for diverse clinical scenarios, supporting acute interventions as well as long-term patient management strategies.

Market Snapshot: Etafenone Market Growth and Trends

The Etafenone Market grew from USD 1.25 billion in 2024 to USD 1.33 billion in 2025. It is expected to continue growing at a CAGR of 6.54%, reaching USD 1.83 billion by 2030. This progress underscores increasing demand for anti-anginal therapies and vasodilator agents as cardiovascular disease persists as a major health priority. Growth is shaped by ongoing innovations in formulation, adaptable care delivery, and regional advances in healthcare infrastructure.

Scope & Segmentation

This research report comprehensively analyzes the Etafenone Market across therapeutic, distribution, end-use, and formulation variables. The scope covers trends, opportunities, and evolving challenges in both established and emerging geographies, as well as technology drivers influencing adoption.

  • Application Areas: Anti-anginal therapies (including stable and unstable angina management) and vasodilator interventions (coronary spasm and peripheral vasodilation).
  • Distribution Channels: E-commerce pharmacies, hospital pharmacies, and retail pharmacies drive product accessibility for inpatient, outpatient, and home care settings.
  • End Users: Home care providers, hospital systems, and specialty clinics comprise the key settings for Etafenone administration.
  • Formulation Formats: Capsule, injectable solution, oral solution, and tablet forms; tablets differentiated further into film-coated and immediate-release options.
  • Geographic Regions: Markets examined include the Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Leading Companies: Analysis includes Bayer Aktiengesellschaft, Sanofi S.A., Alfasigma S.p.A., Ferrer Internacional S.A., OJSC Pharmstandard, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., and Lupin Limited.

Key Takeaways for Senior Decision-Makers

  • The Etafenone Market’s growth is fueled by its dual utility as both anti-anginal and vasodilator, meeting the spectrum of cardiovascular patient needs.
  • Industry innovation is moving toward patient-specific delivery mechanisms, such as rapid-onset or sustained-release options, to enhance clinical impact and adherence.
  • Strategic partnerships between biotech innovators, CDMOs, and major pharmaceutical firms are accelerating development timelines and ensuring scalable production capacity.
  • Competitive differentiation is increasingly tied to patent portfolios, proprietary formulation platforms, and digital health integrations that support remote monitoring and adherence tracking.
  • Regional variation in reimbursement systems, regulatory frameworks, and local manufacturing incentives continues to influence national adoption rates and market entry challenges.
  • Manufacturers are responding to evolving market needs by diversifying distribution strategies to balance e-commerce convenience with hospital and retail pharmacy accessibility.

Tariff Impact on the Etafenone Market

In 2025, revised US tariff policies targeting pharmaceuticals directly affected Etafenone manufacturers, with increases in duties on critical raw materials. Companies responded by restructuring global supply chains, near-shoring active ingredient production, and renegotiating sourcing contracts. While these trends temporarily increased input costs, they also spurred the development of more resilient manufacturing and supply strategies, as well as repricing negotiations with healthcare payers to maintain market competitiveness.

Methodology & Data Sources

Research for this report integrates insights from clinical expert interviews, peer-reviewed journals, regulatory records, and proprietary industry surveys. Data integrity was ensured through cross-validation using clinical, supply chain, and prescription datasets. Regional nuances and competitive intelligence were mapped using patent filings, partnership disclosures, and input from local market consultants, with all sources documented for transparency.

Why This Report Matters

  • Delivers actionable intelligence to inform strategic planning, supply chain realignment, and product development in the cardiovascular therapeutics sector.
  • Enables benchmarking against leading competitors and best practices in differentiation, digital integration, and market access strategies.
  • Highlights the interplay of emerging patient segments, technology adoption, and regulatory changes influencing commercial success.

Conclusion

Etafenone is positioned as a versatile solution addressing the changing landscape of cardiovascular care. Businesses utilizing these insights can build supply flexibility, boost clinical adoption, and enhance differentiation as market demands evolve.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Etafenone Market, by Application
8.1. Introduction
8.2. Anti Anginal
8.2.1. Stable Angina
8.2.2. Unstable Angina
8.3. Vasodilator Agents
8.3.1. Coronary Spasm
8.3.2. Peripheral Vasodilation
9. Etafenone Market, by Distribution Channel
9.1. Introduction
9.2. E Commerce Pharmacies
9.3. Hospital Pharmacies
9.4. Retail Pharmacies
10. Etafenone Market, by End User
10.1. Introduction
10.2. Home Care Settings
10.3. Hospitals
10.4. Specialty Clinics
11. Etafenone Market, by Form
11.1. Introduction
11.2. Capsule
11.3. Injectable Solution
11.4. Oral Solution
11.5. Tablet
11.5.1. Film Coated
11.5.2. Immediate Release
12. Americas Etafenone Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Etafenone Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Etafenone Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Bayer Aktiengesellschaft
15.3.2. Sanofi S.A.
15.3.3. Alfasigma S.p.A.
15.3.4. Ferrer Internacional, S.A.
15.3.5. OJSC Pharmstandard
15.3.6. Teva Pharmaceutical Industries Ltd.
15.3.7. Sandoz International GmbH
15.3.8. Sun Pharmaceutical Industries Ltd.
15.3.9. Dr. Reddy’s Laboratories Ltd.
15.3.10. Lupin Limited
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ETAFENONE MARKET MULTI-CURRENCY
FIGURE 2. ETAFENONE MARKET MULTI-LANGUAGE
FIGURE 3. ETAFENONE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ETAFENONE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ETAFENONE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ETAFENONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ETAFENONE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ETAFENONE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ETAFENONE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ETAFENONE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ETAFENONE MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ETAFENONE MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ETAFENONE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ETAFENONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ETAFENONE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ETAFENONE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ETAFENONE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ETAFENONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ETAFENONE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ETAFENONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ETAFENONE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ETAFENONE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ETAFENONE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ETAFENONE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ETAFENONE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ETAFENONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ETAFENONE MARKET SIZE, BY ANTI ANGINAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ETAFENONE MARKET SIZE, BY STABLE ANGINA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ETAFENONE MARKET SIZE, BY UNSTABLE ANGINA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ETAFENONE MARKET SIZE, BY CORONARY SPASM, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ETAFENONE MARKET SIZE, BY PERIPHERAL VASODILATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ETAFENONE MARKET SIZE, BY E COMMERCE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ETAFENONE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ETAFENONE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ETAFENONE MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ETAFENONE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ETAFENONE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ETAFENONE MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ETAFENONE MARKET SIZE, BY INJECTABLE SOLUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ETAFENONE MARKET SIZE, BY ORAL SOLUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ETAFENONE MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ETAFENONE MARKET SIZE, BY FILM COATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ETAFENONE MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS ETAFENONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES ETAFENONE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 47. CANADA ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. CANADA ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 49. CANADA ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 50. CANADA ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. CANADA ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. CANADA ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 53. CANADA ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 54. MEXICO ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. MEXICO ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 56. MEXICO ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 57. MEXICO ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. MEXICO ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. MEXICO ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 60. MEXICO ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA ETAFENONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. UNITED KINGDOM ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. UNITED KINGDOM ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 85. UNITED KINGDOM ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 86. UNITED KINGDOM ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. UNITED KINGDOM ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. UNITED KINGDOM ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 89. UNITED KINGDOM ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 90. GERMANY ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. GERMANY ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 92. GERMANY ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 93. GERMANY ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. GERMANY ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. GERMANY ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 96. GERMANY ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 97. FRANCE ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. FRANCE ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 99. FRANCE ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 100. FRANCE ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. FRANCE ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. FRANCE ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 103. FRANCE ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 104. RUSSIA ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. RUSSIA ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 106. RUSSIA ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 107. RUSSIA ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. RUSSIA ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. RUSSIA ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 110. RUSSIA ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 111. ITALY ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. ITALY ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 113. ITALY ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 114. ITALY ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. ITALY ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. ITALY ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 117. ITALY ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 118. SPAIN ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. SPAIN ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 120. SPAIN ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 121. SPAIN ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. SPAIN ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. SPAIN ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 124. SPAIN ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 125. UNITED ARAB EMIRATES ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. UNITED ARAB EMIRATES ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 127. UNITED ARAB EMIRATES ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 128. UNITED ARAB EMIRATES ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. UNITED ARAB EMIRATES ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. UNITED ARAB EMIRATES ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 131. UNITED ARAB EMIRATES ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 132. SAUDI ARABIA ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. SAUDI ARABIA ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 134. SAUDI ARABIA ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 135. SAUDI ARABIA ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. SAUDI ARABIA ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. SAUDI ARABIA ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 138. SAUDI ARABIA ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 139. SOUTH AFRICA ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. SOUTH AFRICA ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 141. SOUTH AFRICA ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 142. SOUTH AFRICA ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. SOUTH AFRICA ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. SOUTH AFRICA ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 145. SOUTH AFRICA ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 146. DENMARK ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. DENMARK ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 148. DENMARK ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 149. DENMARK ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. DENMARK ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. DENMARK ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 152. DENMARK ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 153. NETHERLANDS ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. NETHERLANDS ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 155. NETHERLANDS ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 156. NETHERLANDS ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. NETHERLANDS ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. NETHERLANDS ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 159. NETHERLANDS ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 160. QATAR ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. QATAR ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 162. QATAR ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 163. QATAR ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. QATAR ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. QATAR ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 166. QATAR ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 167. FINLAND ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. FINLAND ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 169. FINLAND ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 170. FINLAND ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. FINLAND ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. FINLAND ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 173. FINLAND ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 181. NIGERIA ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. NIGERIA ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 183. NIGERIA ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 184. NIGERIA ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. NIGERIA ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. NIGERIA ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 187. NIGERIA ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 188. EGYPT ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. EGYPT ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 190. EGYPT ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 191. EGYPT ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. EGYPT ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. EGYPT ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 194. EGYPT ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 195. TURKEY ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. TURKEY ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 197. TURKEY ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 198. TURKEY ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 199. TURKEY ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. TURKEY ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 201. TURKEY ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 202. ISRAEL ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. ISRAEL ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 204. ISRAEL ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 205. ISRAEL ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. ISRAEL ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. ISRAEL ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 208. ISRAEL ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 209. NORWAY ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. NORWAY ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 211. NORWAY ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 212. NORWAY ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. NORWAY ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. NORWAY ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 215. NORWAY ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 216. POLAND ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. POLAND ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 218. POLAND ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 219. POLAND ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. POLAND ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. POLAND ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 222. POLAND ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 223. SWITZERLAND ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. SWITZERLAND ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 225. SWITZERLAND ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 226. SWITZERLAND ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. SWITZERLAND ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. SWITZERLAND ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 229. SWITZERLAND ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 230. ASIA-PACIFIC ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. ASIA-PACIFIC ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 232. ASIA-PACIFIC ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC ETAFENONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 238. CHINA ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. CHINA ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 240. CHINA ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 241. CHINA ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. CHINA ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. CHINA ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 244. CHINA ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 245. INDIA ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. INDIA ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 247. INDIA ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 248. INDIA ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. INDIA ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. INDIA ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 251. INDIA ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 252. JAPAN ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. JAPAN ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 254. JAPAN ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 255. JAPAN ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 256. JAPAN ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. JAPAN ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 258. JAPAN ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 259. AUSTRALIA ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. AUSTRALIA ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 261. AUSTRALIA ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 266. SOUTH KOREA ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. SOUTH KOREA ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 268. SOUTH KOREA ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 269. SOUTH KOREA ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 270. SOUTH KOREA ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. SOUTH KOREA ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 273. INDONESIA ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. INDONESIA ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 275. INDONESIA ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 280. THAILAND ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. THAILAND ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 282. THAILAND ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 283. THAILAND ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 284. THAILAND ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. THAILAND ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 286. THAILAND ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 287. PHILIPPINES ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. PHILIPPINES ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 289. PHILIPPINES ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 290. PHILIPPINES ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 291. PHILIPPINES ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. PHILIPPINES ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 293. PHILIPPINES ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 294. MALAYSIA ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 295. MALAYSIA ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 296. MALAYSIA ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 297. MALAYSIA ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 301. SINGAPORE ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 302. SINGAPORE ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 303. SINGAPORE ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 304. SINGAPORE ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 305. SINGAPORE ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. SINGAPORE ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 307. SINGAPORE ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 308. VIETNAM ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 309. VIETNAM ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 310. VIETNAM ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 311. VIETNAM ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 312. VIETNAM ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 313. VIETNAM ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 314. VIETNAM ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 315. TAIWAN ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 316. TAIWAN ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2030 (USD MILLION)
TABLE 317. TAIWAN ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2030 (USD MILLION)
TABLE 318. TAIWAN ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 319. TAIWAN ETAFENONE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. TAIWAN ETAFENONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 321. TAIWAN ETAFENONE MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 322. ETAFENONE MARKET SHARE, BY KEY PLAYER, 2024
TABLE 323. ETAFENONE MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Etafenone market report include:
  • Bayer Aktiengesellschaft
  • Sanofi S.A.
  • Alfasigma S.p.A.
  • Ferrer Internacional, S.A.
  • OJSC Pharmstandard
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • Lupin Limited

Table Information

Report AttributeDetails
No. of Pages190
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.33 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.83 Billion
Compound Annual Growth Rate6.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Etafenone (CAS 90-54-0) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Etafenone (CAS 90-54-0) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Angina Pectoris Drugs Market by Drug Class, Dosage Form, Route Of Administration, Distribution Channel, End User - Global Forecast to 2030 - Product Image

Angina Pectoris Drugs Market by Drug Class, Dosage Form, Route Of Administration, Distribution Channel, End User - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From
Antihypertensive Drugs Market by Therapeutic Class, Therapy Type, Administration Route, Dosage Form, Distribution Channel, End Users - Global Forecast to 2030 - Product Image

Antihypertensive Drugs Market by Therapeutic Class, Therapy Type, Administration Route, Dosage Form, Distribution Channel, End Users - Global Forecast to 2030

  • Report
  • 193 Pages
  • Global
From
Ischemic Heart Disease (IHD) Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Ischemic Heart Disease (IHD) Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Ischemic Heart Disease (IHD) Drugs Market Report 2025 - Product Image

Ischemic Heart Disease (IHD) Drugs Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Etafenone Market

Etafenone is a cardiovascular drug used to treat angina pectoris, a type of chest pain caused by reduced blood flow to the heart. It is a type of calcium channel blocker, which works by relaxing the muscles of the heart and blood vessels, allowing for improved blood flow. Etafenone is available in both oral and intravenous forms, and is often used in combination with other medications to treat angina. Etafenone is a relatively new drug, having been approved by the US Food and Drug Administration in 2019. It is used to treat angina in patients who have not responded to other treatments, and is generally well-tolerated. The market for Etafenone is growing, as more patients are turning to this drug as an alternative to other treatments. It is becoming increasingly popular among physicians and patients alike, due to its effectiveness and safety profile. Some companies in the Etafenone market include Merck, Pfizer, and Novartis. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.